Empowered Funds
MGNX icon

Empowered Funds’s MacroGenics MGNX Stock Holding History

Empowered Funds’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$279K Buy
+72,276
New +$298K ﹤0.01% 2074

Other funds holding MGNX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Empowered Funds's MGNX Position: Q3 2026 in Review

Empowered Funds opened a new position in MacroGenics (MGNX) in Q3 2026: 72,276 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #2074 among its holdings.

84 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.

  • Empowered Funds held 72,276 shares of MacroGenics worth $279K as of Q3 2026.
  • MacroGenics was a new Empowered Funds position in Q3 2026.
  • MacroGenics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2074 holding.
  • 84 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.